QR Code

Setmelanotide-mediated MC4R activation improves hypothalamic obesity via CaMKK2/AMPK pathways

Hypothalamic obesity (HO) is a disabling disease caused by central nervous system (CNS) damage due to neurosurgery, trauma, or tumors, especially in hypothalamus. The pathological mechanism of its neural circuits is still unclear, and there is currently no corresponding drug due to the complex etiol...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Junjie Peng, Yichao Ou, Mingfeng Zhou, Xingqin Wang, Xi’an Zhang, Hao Long, Guangsen Wu, Mengjie Che, Kai Li, Le Yang, Zhu Zhang, Ken Kin Lam Yung, Songtao Qi, Zhanpeng Feng
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Frontiers Media S.A. 2026-01-01
Rangatū:Frontiers in Pharmacology
Ngā marau:
CaMKK2/AMPK signaling
GPCRs
hypothalamic obesity
melanocortin 4 receptor
neuropharmacology
setmelanotide
Urunga tuihono:https://www.frontiersin.org/articles/10.3389/fphar.2025.1730786/full
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite